Kajian klinikal Kejang di Illinois
8 kajian untuk Kejang sedang mencari peserta di lokasi di Illinois.
Bandar di Illinois
Teks kajian rasmi (Bahasa Inggeris)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Re:Cognition Health, Chicago
Mengambil pesertaFasa 3
Umur 2 hingga 55 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Northwestern University, Chicago
Mengambil pesertaFasa 1
Umur 12 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Southern Illinois University School of Medicine, Springfield
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07594119Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Mengambil pesertaKajian pemerhatian
Sehingga umur 26 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
Mengambil pesertaFasa 3
1 Day – 18 Years · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT05716100Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.